世界の手術用顕微鏡市場は、2024年に13億3,000万ドルと評価され、2025年には15億1,000万ドルに達し、2025年から2030年にかけてCAGR 11.4%で堅調に成長し、2030年末には26億9,000万ドルに達すると予測されます。手術用顕微鏡市場は、インド、ブラジル、ベトナムなどの新興国に牽引され、成長が見込まれています。これらの国々は急速な経済発展を遂げており、可処分所得の増加に伴い中流階級が台頭しています。
目次
TABLE OF CONTENTS
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key secondary data
2.1.1.2 Key secondary data sources
2.1.1.3 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key primary sources
2.1.2.2 Key objectives of primary research
2.1.2.3 Key data from primary sources
2.1.2.4 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.2.1 REVENUE SHARE ANALYSIS
2.2.2 BOTTOM-UP APPROACH (SUPPLY-SIDE ANALYSIS)
2.2.3 COMPANY PRESENTATIONS & PRIMARY INTERVIEWS
2.2.4 TOP-DOWN APPROACH
2.3 DATA TRIANGULATION
2.4 MARKET SHARE ESTIMATION
2.5 STUDY ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.6.1 SCOPE-RELATED LIMITATIONS
2.6.2 METHODOLOGY-RELATED LIMITATIONS
2.7 RISK ANALYSIS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 SURGICAL MICROSCOPES MARKET OVERVIEW
4.2 ASIA PACIFIC: SURGICAL MICROSCOPES MARKET, BY TYPE AND COUNTRY
4.3 SURGICAL MICROSOCPES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.4 SURGICAL MICROSCOPES MARKET: REGIONAL MIX, 2023-2030
4.5 SURGICAL MICROSCOPES MARKET: EMERGING VS. DEVELOPED MARKETS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Global rise in geriatric population
5.2.1.2 Increase in general and specialty surgical procedures
5.2.1.3 Technological advancements in surgical/operating microscopes
5.2.2 RESTRAINTS
5.2.2.1 High initial capital and maintenance cost of surgical microscopes
5.2.3 OPPORTUNITIES
5.2.3.1 High growth potential in emerging economies
5.2.3.2 Global expansion of hospital infrastructure
5.2.4 CHALLENGES
5.2.4.1 Dearth of skilled personnel
5.2.4.2 Stringent regulatory requirements for surgical microscopes
5.3 INDUSTRY TRENDS
5.3.1 4K 3D VISUALIZATION TECHNOLOGY
5.3.2 AUGMENTED REALITY
5.3.3 ERGONOMIC DESIGN
5.4 TECHNOLOGY ANALYSIS
5.4.1 KEY TECHNOLOGIES
5.4.1.1 Optical lens systems
5.4.2 COMPLEMENTARY TECHNOLOGIES
5.4.2.1 HD monitors
5.4.2.2 Fluorescence imaging modules
5.4.3 ADJACENT TECHNOLOGIES
5.4.3.1 Surgical lighting systems
5.5 PRICING ANALYSIS
5.5.1 AVERAGE SELLING PRICE TREND OF SURGICAL MICROSCOPES, BY KEY PLAYER, 2022-2024
5.5.2 AVERAGE SELLING PRICE TREND OF SURGICAL MICROSCOPES, BY REGION, 2022-2024
5.6 ECOSYSTEM ANALYSIS
5.6.1 ROLE IN ECOSYSTEM
5.7 REIMBURSEMENT SCENARIO ANALYSIS
5.8 VALUE CHAIN ANALYSIS
5.9 PORTER'S FIVE FORCES ANALYSIS
5.9.1 INTENSITY OF COMPETITIVE RIVALRY
5.9.2 BARGAINING POWER OF SUPPLIERS
5.9.3 BARGAINING POWER OF BUYERS
5.9.4 THREAT OF SUBSTITUTES
5.9.5 THREAT OF NEW ENTRANTS
5.10 KEY STAKEHOLDERS & BUYING CRITERIA
5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.10.2 KEY BUYING CRITERIA
5.11 SUPPLY CHAIN ANALYSIS
5.12 TRADE ANALYSIS
5.12.1 IMPORT DATA FOR HS CODE 901180, 2020-2024
5.12.2 EXPORT DATA FOR HS CODE 901180, 2020-2024
5.13 REGULATORY ANALYSIS
5.13.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.13.2 REGULATORY FRAMEWORK
5.13.2.1 North America
5.13.2.1.1 US
5.13.2.1.2 Canada
5.13.2.2 Europe
5.13.2.3 Asia Pacific
5.13.2.3.1 Japan
5.13.2.3.2 China
5.13.2.3.3 India
5.14 PATENT ANALYSIS
5.14.1 PATENT PUBLICATION TRENDS FOR SURGICAL MICROSCOPES MARKET
5.14.2 JURISDICTION ANALYSIS: TOP APPLICANTS FOR PATENTS IN SURGICAL MICROSCOPES MARKET
5.14.3 LIST OF MAJOR PATENTS
5.15 KEY CONFERENCES & EVENTS, 2025-2026
5.16 ADJACENT MARKET ANALYSIS
5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
5.18 UNMET NEEDS/END-USER EXPECTATIONS
5.18.1 UNMET NEEDS
5.18.2 END-USER EXPECTATIONS
5.19 IMPACT OF AI/GEN AI ON SURGICAL MICROSCOPES MARKET
5.20 CASE STUDY ANALYSIS
5.20.1 XIJING HOSPITAL TO INTEGRATE ALLTION AOMS 1600 SURGICAL MICROSCOPE FOR BETTER PRECISION SURGERY
5.20.2 KING FAISAL HOSPITAL RWANDA TO ACQUIRE EAST AFRICA'S FIRST ZEISS KINEVO 900S
5.20.3 UNIVERSITY OF CHICAGO TO ENHANCE SURGICAL VERSATILITY WITH LEICA PROVEO 8 UPGRADEABLE OPHTHALMIC MICROSCOPE PLATFORM
5.21 INVESTMENT & FUNDING SCENARIO
5.22 IMPACT OF 2025 US TARIFF ON SURGICAL MICROSCOPES MARKET
5.22.1 INTRODUCTION
5.22.2 KEY TARIFF RATES
5.22.3 PRICE IMPACT ANALYSIS
5.22.4 IMPACT ON COUNTRY/REGION
5.22.4.1 North America
5.22.4.1.1 US
5.22.4.2 Europe
5.22.4.3 Asia Pacific
5.22.5 IMPACT ON END-USE INDUSTRIES
6 SURGICAL MICROSCOPES MARKET, BY TYPE
6.1 INTRODUCTION
6.2 DEVICES
6.2.1 DEVICES COMMANDED LARGEST SHARE IN SURGICAL MICROSCOPES TYPE MARKET IN 2024
6.3 ACCESSORIES
6.3.1 ACCESSORIES TO ENHANCE FUNCTIONALITY, VERSATILITY, AND EASE OF USE IN COMPLEX PROCEDURES
6.4 SOFTWARE
6.4.1 ADVANCED SURGICAL MICROSCOPE SOFTWARE TO PROVIDE BETTER PRECISION, VISUALIZATION, AND WORKFLOW EFFICIENCY
7 SURGICAL MICROSCOPES MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 NEURO & SPINE SURGERY
7.2.1 INCREASING R&D ACTIVITIES ON TISSUE CLEARING AND TARGETED CELL LABELING FOR BRAIN FUNCTIONS TO AID MARKET GROWTH
7.3 PLASTIC & RECONSTRUCTIVE SURGERY
7.3.1 POPULARITY OF COSMETIC PROCEDURES TO AUGMENT MARKET GROWTH
7.4 OPHTHALMOLOGY
7.4.1 RISING PREVALENCE OF GLAUCOMA TO SUPPORT MARKET GROWTH
7.5 GYNECOLOGY & UROLOGY
7.5.1 RISING DEMAND FOR MINIMALLY INVASIVE GYNECOLOGY SURGERIES TO FAVOR MARKET GROWTH
7.6 ONCOLOGY
7.6.1 HIGH CANCER BURDEN TO INCREASE ADOPTION OF SURGICAL MICROSCOPES FOR DIAGNOSIS AND TREATMENT
7.7 ENT SURGERY
7.7.1 INCREASED PREVALENCE OF CHRONIC SINUSITIS AND FAVORABLE REIMBURSEMENT POLICIES TO DRIVE MARKET
7.8 DENTISTRY
7.8.1 LESS PATIENT DISCOMFORT AND HIGH PRECISION OF MICROSURGICAL INCISIONS & SUTURING TO AID MARKET GROWTH
7.9 OTHER APPLICATIONS
8 SURGICAL MICROSCOPES MARKET, BY END USER
8.1 INTRODUCTION
8.2 HOSPITALS
8.2.1 HOSPITALS COMMANDED LARGEST SHARE IN SURGICAL MICROSCOPES END USER MARKET IN 2024
8.3 OUTPATIENT FACILITIES
8.3.1 COST-EFFECTIVENESS AND PREFERENCE FOR MINIMAL HOSPITALIZATION TO FAVOR MARKET GROWTH
8.4 OTHER END USERS
9 SURGICAL MICROSCOPES MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
9.2.2 US
9.2.2.1 US to dominate North American surgical microscopes market during forecast period
9.2.3 CANADA
9.2.3.1 Rising demand for surgical procedures to support market growth
9.3 EUROPE
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
9.3.2 GERMANY
9.3.2.1 Favorable healthcare initiatives and increased adoption of surgical robots to propel market growth
9.3.3 UK
9.3.3.1 Demand for precision medicines and favorable public health policies to drive market
9.3.4 FRANCE
9.3.4.1 Advancements in minimally invasive surgeries and increased adoption of precision technologies to fuel market growth
9.3.5 SPAIN
9.3.5.1 Advancements in microsurgical techniques and strong public healthcare infrastructure to augment market growth
9.3.6 ITALY
9.3.6.1 Emphasis on modernizing surgical infrastructure to boost market growth
9.3.7 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
9.4.2 CHINA
9.4.2.1 Advanced healthcare infrastructure and favorable government policies to drive market
9.4.3 INDIA
9.4.3.1 Modernization of public & private healthcare infrastructure and high surgical volumes to propel market growth
9.4.4 SOUTH KOREA
9.4.4.1 Advanced healthcare system and high volume of complex surgeries to spur market growth
9.4.5 JAPAN
9.4.5.1 High geriatric population and popularity of minimally invasive surgeries to propel market growth
9.4.6 AUSTRALIA
9.4.6.1 Adoption of advanced medical technologies for high-precision surgical outcomes to favor market growth
9.4.7 REST OF ASIA PACIFIC
9.5 LATIN AMERICA
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
9.5.2 BRAZIL
9.5.2.1 Growing prevalence of colorectal cancer and inflammatory bowel disease to support market growth
9.5.3 MEXICO
9.5.3.1 Increasing popularity of medical tourism to favor market growth
9.5.4 REST OF LATIN AMERICA
9.6 MIDDLE EAST & AFRICA
9.6.1 NEED FOR ADVANCED MEDICAL TECHNOLOGIES TO DRIVE DEMAND FOR SURGICAL MICROSCOPES
9.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
9.7 GCC COUNTRIES
9.7.1 STRONG HEALTHCARE SECTOR AND FAVORABLE GOVERNMENT STRATEGIC INITIATIVES TO PROPEL MARKET GROWTH
9.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SURGICAL MICROSCOPES MARKET
10.3 REVENUE ANALYSIS, 2020-2024
10.4 MARKET SHARE ANALYSIS, 2024
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
10.5.5.1 Company footprint
10.5.5.2 Region footprint
10.5.5.3 Type footprint
10.5.5.4 Application footprint
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
10.6.1 PROGRESSIVE COMPANIES
10.6.2 RESPONSIVE COMPANIES
10.6.3 DYNAMIC COMPANIES
10.6.4 STARTING BLOCKS
10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
10.6.5.1 Detailed list of key startups/SMEs
10.6.5.2 Competitive benchmarking of key startups/SMEs
10.7 COMPANY VALUATION & FINANCIAL METRICS
10.7.1 FINANCIAL METRICS
10.7.2 COMPANY VALUATION
10.8 BRAND/PRODUCT COMPARISON
10.9 R&D EXPENDITURE OF KEY PLAYERS
10.10 COMPETITIVE SCENARIO
10.10.1 PRODUCT LAUNCHES & APPROVALS
10.10.2 DEALS
10.10.3 EXPANSIONS
10.10.4 OTHER DEVELOPMENTS
11 COMPANY PROFILES
11.1 KEY PLAYERS
11.1.1 CARL ZEISS MEDITEC AG
11.1.1.1 Business overview
11.1.1.2 Products offered
11.1.1.3 Recent developments
11.1.1.3.1 Product launches
11.1.1.3.2 Deals
11.1.1.3.3 Expansions
11.1.1.4 MnM view
11.1.1.4.1 Right to win
11.1.1.4.2 Strategic choices
11.1.1.4.3 Weaknesses & competitive threats
11.1.2 DANAHER (LEICA MICROSYSTEMS)
11.1.2.1 Business overview
11.1.2.2 Products offered
11.1.2.3 Recent developments
11.1.2.3.1 Product launches
11.1.2.3.2 Deals
11.1.2.3.3 Expansions
11.1.2.3.4 Other developments
11.1.2.4 MnM view
11.1.2.4.1 Right to win
11.1.2.4.2 Strategic choices
11.1.2.4.3 Weaknesses & competitive threats
11.1.3 ALCON
11.1.3.1 Business overview
11.1.3.2 Products offered
11.1.3.3 Recent developments
11.1.3.3.1 Expansions
11.1.3.4 MnM view
11.1.3.4.1 Right to win
11.1.3.4.2 Strategic choices
11.1.3.4.3 Weaknesses & competitive threats
11.1.4 HAAG-STREIT GROUP
11.1.4.1 Business overview
11.1.4.2 Products offered
11.1.4.3 Recent developments
11.1.4.3.1 Product launches
11.1.4.3.2 Expansions
11.1.4.4 MnM view
11.1.4.4.1 Right to win
11.1.4.4.2 Strategic choices
11.1.4.4.3 Weaknesses & competitive threats
11.1.5 OLYMPUS CORPORATION
11.1.5.1 Business overview
11.1.5.2 Products offered
11.1.5.3 Recent developments
11.1.5.3.1 Expansions
11.1.5.4 MnM view
11.1.5.4.1 Right to win
11.1.5.4.2 Strategic choices
11.1.5.4.3 Weaknesses & competitive threats
11.1.6 ALLTION (GUANGXI) INSTRUMENT CO., LTD.
11.1.6.1 Business overview
11.1.6.2 Products offered
11.1.6.3 Recent developments
11.1.6.3.1 Product launches & approvals
11.1.6.3.2 Expansions
11.1.7 TOPCON CORPORATION
11.1.7.1 Business overview
11.1.7.2 Products offered
11.1.7.3 Recent developments
11.1.7.3.1 Deals
11.1.7.3.2 Expansions
11.1.8 GLOBAL SURGICAL CORPORATION
11.1.8.1 Business overview
11.1.8.2 Products offered
11.1.9 TAKAGI SEIKO CO., LTD.
11.1.9.1 Business overview
11.1.9.2 Products offered
11.1.9.3 Recent developments
11.1.9.3.1 Expansions
11.1.10 KARL KAPS GMBH & CO. KG
11.1.10.1 Business overview
11.1.10.2 Products offered
11.2 OTHER PLAYERS
11.2.1 MITAKA KOHKI CO., LTD.
11.2.2 SEILER INSTRUMENT INC.
11.2.3 ATMOS MEDIZINTECHNIK GMBH & CO. KG
11.2.4 AVANTE HEALTH SOLUTIONS
11.2.5 ARI MEDICAL TECHNOLOGY CO., LTD.
11.2.6 MUNICH SURGICAL IMAGING GMBH
11.2.7 OPTOFINE INSTRUMENTS PVT. LTD.
11.2.8 DONG-A CHAMMED
11.2.9 LABOMED WORLD
11.2.10 ZUMAX MEDICAL CO., LTD.
11.2.11 SYNAPTIVE MEDICAL
11.2.12 BHS TECHNOLOGIES GMBH
11.2.13 MATRONIX OPTOTECHNIK PRIVATE LIMITED
11.2.14 MEDICARE SURGICAL
11.2.15 QUASMO
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
